methylprednisolone has been researched along with epidermal growth factor in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gerdin, B; Heino, J; Kähäri, VM; Laato, M; Niinikoski, J | 1 |
Laato, M | 1 |
Ogborn, MR; Sareen, S | 1 |
3 other study(ies) available for methylprednisolone and epidermal growth factor
Article | Year |
---|---|
Epidermal growth factor (EGF) prevents methylprednisolone-induced inhibition of wound healing.
Topics: Animals; Collagen; DNA; Epidermal Growth Factor; Fibronectins; Glyceraldehyde-3-Phosphate Dehydrogenases; Hexosamines; Hydroxyproline; Male; Methylprednisolone; Neutrophils; Procollagen; Prostheses and Implants; Rats; Rats, Inbred Strains; RNA; RNA, Messenger; Uronic Acids; Wound Healing | 1989 |
The effect of epidermal growth factor on granulation tissue formation in the rat.
Topics: Animals; Collagen; Epidermal Growth Factor; Granulation Tissue; Male; Methylprednisolone; Rats; Rats, Inbred Strains | 1988 |
Transforming growth factor alpha and epidermal growth factor expression in experimental murine polycystic kidney disease.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Disease Models, Animal; Epidermal Growth Factor; Immunohistochemistry; Methylprednisolone; Methylprednisolone Acetate; Mice; Mice, Inbred C3H; Polycystic Kidney Diseases; Transforming Growth Factor alpha | 1996 |